Evidence map›Paper›PMID 36363465›Full record

ArticleMedicina (Kaunas, Lithuania)2022

The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy.

Omar M Halalsheh, Yazan O Al Zu'bi, Ahmed H Al Sharie, Farouk H Wafai, Nadeem Alabdallah, Jumana AlSeidi, Alia A Hussein, Majd N Daoud, Abubaker A Malkawi, Ahmad O Alomari and 1 more

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Omar M HalalshehDivision of Urology, Department of General Surgery and Urology, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Yazan O Al Zu'biFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Ahmed H Al SharieFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Farouk H WafaiFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.ORCID 0000-0002-0408-2600
Nadeem AlabdallahFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.ORCID 0000-0003-3258-8083
Jumana AlSeidiFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Alia A HusseinFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Majd N DaoudFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Abubaker A MalkawiFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Ahmad O AlomariFaculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.ORCID 0000-0002-5564-4925
Osama AlshariDivision of Oncology, Department of Internal Medicine, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Jordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorHumansLymphocytesNeutrophilsPrognosisRetrospective StudiesGranulocyte Colony-Stimulating Factorchemotherapyfebrile neutropeniaG-CSFgranulocyte colony-stimulating factorlymphocyte ratioslymphopenia

Identifiers

PMID36363465
PMCPMC9695543
OpenAlexW4307264333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.